Shopping Cart (0)
My Account

Your Shopping Cart
Academic Screening Workshop

Academic Screening Workshop



This interactive forum will give delegates the opportunity to learn as well as share experiences about drug discovery in general, academic screening operations, academia-industry collaborative efforts, and recent trends from the industry service-providers for HTS, chemical libraries, high content screening and RNAi technologies. Organised by Dr Hakim Djaballah, director of the HTS facility at Memorial Sloan-Kettering Cancer Center, our 2nd annual Academic Screening Workshop will take place in Baltimore, USA.  Whether delegates are looking to expand their basic knowledge or requiring more of an insight to aid and foster future collaborations, this workshop is highly recommended to anyone working or has an interest in discovery and technology development.

The workshop aims to help energize the discovery paradigm through open panel discussions on highly provocative topics such as the future of academic screening operations post the NIH Roadmap and should academia be doing drug discovery? It is hoped that through these kind of open discussions, delegates will have the opportunity to build their own consensus and bring their points of view across. The field is seeking new ideas and inputs to discover novel or repurpose known drugs to fight disease whether in a pharmaceutical or academic setting. This will be possible through innovative technologies provided by companies such as Cellectricon or Prestwick dedicated to supporting the discovery paradigm across various disciplines.

We look forward to welcoming you to our 2nd Annual Academic Screening Workshop and we hope the two days will be both enjoyable and informative.


Keynote Speakers

Hakim Djaballah

Hakim Djaballah
Director, Memorial Sloan Kettering Cancer Center

Agenda Topics

  • Academia - Industry Collaborative Initiatives
  • Academic & Not-for-Profit Screening Operations
  • Future of Big Pharma Discovery Platforms
  • Novel and Enabling Screening Technologies in 2012
  • RNAi Technologies 2012
  • Should Academia be doing Drug Discovery
  • Showcasing your Screening Lab: Capability & Capacity
  • Vendor/User Perspectives on HCA in 2012

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44(0)1787 315110

Confirmed Speakers to date

Ricardo Macarron, Vice President, GlaxoSmithKline
Larry Sklar, Director, University of New Mexico Health Sciences Center
John Watson, Head of New Markets, Promega
Paul Johnston, Research Associate Professor, University of Pittsburgh
Christophe Antczak, Assistant Director, Memorial Sloan Kettering Cancer Center
Haian Fu, Co-Principal Investigator, Emory University
Terry Riss, Senior Project Manager, Promega
Rathnam Chaguturu, Founder and CEO, iDDPartners
Michael Walters, Director of Combinatorial Chemistry Laboratory, University of Minnesota
Thomas Chung, Director of Outreach/Project Manager, Sanford Burnham Medical Research Institute
Peter Brown, Group Leader, University of Toronto
Robert Zivin, Research Associate Professor, University of Miami
Christopher Austin, Director, National Institutes of Health
Bahne Stechmann, Scientific Manager, Leibniz-Institut für Molekulare Pharmakologie
Mohan Thiruvazhi, Director, GVK Bio
John Hayley, Senior Director, EMT, Biology, OSI Pharmaceuticals


Corporate Sponsors Media Sponsors Networking
U-Networks




There is currently no news for this conference.
    Keep me updated Select Bio Blog Linked in Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com